A new affordable and effective drug to help manage Type 2 diabetes in Ghana has been introduced in the country.

Global diabetes rates quadrupled since 1990, affecting 828 million adults, with treatment disparities persisting.

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

A new study reveals a staggering 828 million adults globally are living with diabetes, double previous estimates. Over half ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who ... their daily routine they can stop taking diabetes medicines that they needed before ...